Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival
- PMID: 8279918
- DOI: 10.1016/0003-4975(94)90364-6
Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival
Abstract
Because of donor scarcity, 12 (39%) of a series of 31 Novacor left ventricular assist system recipients required mechanical circulatory support for an average of 125 days before transplantation (range, 61 to 303 days). Ten received a heart transplant and all survived to discharge. Two died of infection before transplantation after 93 and 303 days of support. Significant reductions were noted from preimplantation values of right and left cardiac filling pressures. Right ventricular ejection fraction and cardiac index increased. The 4-month actuarial freedom from infection during support was 75%. Three patients benefited from chronic outpatient housing for 5, 18, and 131 days, respectively, with improvements in quality of life measures. Ten chronically supported patients participated in an intensive rehabilitative exercise program resulting in an improvement of New York Heart Association class from IV to I in 9 patients. Mean oxygen consumption, which was 10 mL.kg-1.min-1 30 days after implantation (mean exercise time, 10 minutes) had risen to 15 mL.kg-1.min-1 before transplantation (mean exercise time, 16 minutes). This series suggests that long-term circulatory support is compatible with low morbidity, significant physical and hemodynamic rehabilitation, and an outpatient setting.
Similar articles
-
Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation.J Am Coll Cardiol. 1993 Nov 15;22(6):1574-80. doi: 10.1016/0735-1097(93)90580-t. J Am Coll Cardiol. 1993. PMID: 8227823
-
Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095. J Thorac Cardiovasc Surg. 2013. PMID: 23321132
-
Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.J Thorac Cardiovasc Surg. 1995 Jan;109(1):74-80. doi: 10.1016/S0022-5223(95)70422-1. J Thorac Cardiovasc Surg. 1995. PMID: 7815810
-
Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.J Thorac Cardiovasc Surg. 1991 Oct;102(4):578-86; discussion 586-7. J Thorac Cardiovasc Surg. 1991. PMID: 1921434 Clinical Trial.
-
[Mechanical circulatory support. 2: Ventricular assist systems].Zentralbl Chir. 1995;120(3):166-73. Zentralbl Chir. 1995. PMID: 7754717 Review. German.
Cited by
-
Hemofiltration for hyperbilirubinemia after left ventricular assist system implantation: report of four cases.Surg Today. 2008;38(8):747-50. doi: 10.1007/s00595-007-3731-1. Epub 2008 Jul 31. Surg Today. 2008. PMID: 18668321
-
Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system.Ann Surg. 1995 Sep;222(3):327-36; discussion 336-8. doi: 10.1097/00000658-199509000-00010. Ann Surg. 1995. PMID: 7677462 Free PMC article. Clinical Trial.
-
Exercise rehabilitation in ventricular assist device recipients: a meta-analysis of effects on physiological and clinical outcomes.Heart Fail Rev. 2019 Jan;24(1):55-67. doi: 10.1007/s10741-018-9695-y. Heart Fail Rev. 2019. PMID: 29623546
-
Myocardial histological changes in dilated cardiomyopathy during a long-term left ventricular assist device support.Heart Vessels. 1997;12(2):98-100. doi: 10.1007/BF02820873. Heart Vessels. 1997. PMID: 9403314
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous